Gene · 2237
Papers3,948
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
941 to 960 of 3,948
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Uncovering potential genes in colorectal cancer based on integrated and DNA methylation analysis in the gene expression omnibus database. | BMC Cancer | 2022 | 35114976 | PubTator, text mining | PubMed |
| Pathogenicity and virulence of Hepatitis B virus. | Virulence | 2022 | 35100095 | PubTator, text mining | PubMed |
| Proteomic and phosphoproteomic profiling of COVID-19-associated lung and liver injury: a report based on rhesus macaques. | Signal Transduct Target Ther | 2022 | 35091530 | PubTator, text mining | PubMed |
| Evidence for Multiple Subpopulations of Herpesvirus-Latently Infected Cells. | mBio | 2022 | 35089062 | PubTator, text mining | PubMed |
| Differential Diagnosis and Molecular Stratification of Gastrointestinal Stromal Tumors on CT Images Using a Radiomics Approach. | J Digit Imaging | 2022 | 35088185 | PubTator, text mining | PubMed |
| Bioactive peptides from broccoli stems strongly enhance regenerative keratinocytes by stimulating controlled proliferation. | Pharm Biol | 2022 | 35086428 | PubTator, text mining | PubMed |
| Identification of GINS2 prognostic potential and involvement in immune cell infiltration in hepatocellular carcinoma. | J Cancer | 2022 | 35069907 | PubTator, text mining | PubMed |
| Targeting PARP proteins in acute leukemia: DNA damage response inhibition and therapeutic strategies. | J Hematol Oncol | 2022 | 35065680 | PubTator, text mining | PubMed |
| CRISPR-based genome editing through the lens of DNA repair. | Mol Cell | 2022 | 35063100 | PubTator, text mining | PubMed |
| Cellular architecture of human brain metastases. | Cell | 2022 | 35063085 | PubTator, text mining | PubMed |
| XRCC1 Prevents Replication Fork Instability during Misincorporation of the DNA Demethylation Bases 5-Hydroxymethyl-2'-Deoxycytidine and 5-Hydroxymethyl-2'-Deoxyuridine. | Int J Mol Sci | 2022 | 35055077 | PubTator, text mining | PubMed |
| Therapeutic implications of germline vulnerabilities in DNA repair for precision oncology. | Cancer Treat Rev | 2022 | 35051883 | PubTator, text mining | PubMed |
| CDK4/6 inhibitors induce replication stress to cause long-term cell cycle withdrawal. | EMBO J | 2022 | 35037284 | PubTator, text mining | PubMed |
| Characterization of the SARS-CoV-2 ExoN (nsp14ExoN-nsp10) complex: implications for its role in viral genome stability and inhibitor identification. | Nucleic Acids Res | 2022 | 35037045 | PubTator, text mining | PubMed |
| Long noncoding RNA LUCAT1 enhances the survival and therapeutic effects of mesenchymal stromal cells post-myocardial infarction. | Mol Ther Nucleic Acids | 2022 | 35036054 | PubTator, text mining | PubMed |
| Host E3 ligase HUWE1 attenuates the proapoptotic activity of the MERS-CoV accessory protein ORF3 by promoting its ubiquitin-dependent degradation. | J Biol Chem | 2022 | 35032548 | PubTator, text mining | PubMed |
| Ribonucleotides embedded in template DNA impair mitochondrial RNA polymerase progression. | Nucleic Acids Res | 2022 | 35018464 | PubTator, text mining | PubMed |
| Heterogeneity of tumor microenvironment is associated with clinical prognosis of non-clear cell renal cell carcinoma: a single-cell genomics study. | Cell Death Dis | 2022 | 35017463 | PubTator, text mining | PubMed |
| Insulin-like growth factor 2 mRNA-binding protein 2-stabilized long non-coding RNA Taurine up-regulated gene 1 (TUG1) promotes cisplatin-resistance of colorectal cancer via modulating autophagy. | Bioengineered | 2022 | 35014946 | PubTator, text mining | PubMed |
| Protein disulfide isomerase A1‑associated pathways in the development of stratified breast cancer therapies. | Int J Oncol | 2022 | 35014681 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2237/papers?page=48